A detailed history of Tabor Asset Management, LP transactions in Scynexis Inc stock. As of the latest transaction made, Tabor Asset Management, LP holds 189,802 shares of SCYX stock, worth $187,903. This represents 0.09% of its overall portfolio holdings.

Number of Shares
189,802
Holding current value
$187,903
% of portfolio
0.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$0.9 - $1.41 $170,821 - $267,620
189,802 New
189,802 $180,000

Others Institutions Holding SCYX

About SCYNEXIS INC


  • Ticker SCYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 32,651,800
  • Market Cap $32.3M
  • Description
  • SCYNEXIS, Inc., a biotechnology company, develops products for the treatment fungal infections in the United States. It offers BREXAFEMME (ibrexafungerp tablets) for the treatment of vulvovaginal candidiasis (VVC). The company is developing its lead product candidate, Ibrexafungerp, as a novel oral and intravenous drug for the treatment of vario...
More about SCYX
Track This Portfolio

Track Tabor Asset Management, LP Portfolio

Follow Tabor Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tabor Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Tabor Asset Management, LP with notifications on news.